Molgramostim topical gel - GeneScience

Drug Profile

Molgramostim topical gel - GeneScience

Alternative Names: Genfulin; GenLei; Topical hGM-CSF; Topical rhGM-CSF

Latest Information Update: 13 Nov 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GeneScience Pharmaceuticals
  • Class Chemoprotectants; Granulocyte-macrophage colony-stimulating factors; Recombinant proteins
  • Mechanism of Action Granulocyte macrophage colony stimulating factor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Burns; Wounds

Most Recent Events

  • 03 May 2017 GeneScience Pharmaceuticals and Shanghai Ninth People 's Hospital plan a clinical trial for Wounds (Intrauterine adhesions) in China (ChiCTR-IPR-17011242)
  • 13 Nov 2009 Molgramostim topical gel is still in preregistration for Wounds in China
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top